Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

14.8%

161 terminated/withdrawn out of 1086 trials

Success Rate

79.0%

-7.6% vs industry average

Late-Stage Pipeline

10%

110 trials in Phase 3/4

Results Transparency

41%

247 of 604 completed trials have results

Key Signals

151 recruiting247 with results93 terminated68 withdrawn

Enrollment Performance

Analytics

N/A
396(46.0%)
Phase 1
220(25.6%)
Phase 2
114(13.2%)
Phase 4
72(8.4%)
Phase 3
38(4.4%)
Early Phase 1
21(2.4%)
861Total
N/A(396)
Phase 1(220)
Phase 2(114)
Phase 4(72)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (1086)

Showing 20 of 1086 trials
NCT01192555Phase 1Active Not Recruiting

Allogeneic Tumor Cell Vaccination With Oral Metronomic Cytoxan in Patients With High-Risk Neuroblastoma

Role: lead

NCT07544979Not ApplicableNot Yet Recruiting

Creation of a Decision Aid for Coronary Anomalies

Role: collaborator

NCT04013802Phase 1Recruiting

TETRAVI Multivirus CTL for Treatment of EBV, CMV, Adenovirus, and BK Infections Post Allogeneic SCT.

Role: lead

NCT02917083Phase 1Recruiting

CD30 CAR T Cells, Relapsed CD30 Expressing Lymphoma (RELY-30)

Role: lead

NCT06596447Recruiting

Neurophysiological Investigation of the Approach-avoidance Axis in OCD: Applications to Neuromodulation

Role: lead

NCT04288726Phase 1Recruiting

Allogeneic CD30.CAR-EBVSTs in Patients With Relapsed or Refractory CD30-Positive Lymphomas

Role: lead

NCT02720679Recruiting

Investigation of the Genetics of Hematologic Diseases

Role: collaborator

NCT07424846Phase 2Recruiting

Xylitol and the Prevention of Periodontal Disease and Preterm Birth Trial

Role: collaborator

NCT05272046Not ApplicableCompleted

Monopolar and Bipolar Current RFA Knife in POEM

Role: lead

NCT01905826Recruiting

Natural History Study of GATA2 Deficiency and Related Disorders

Role: collaborator

NCT05820555Not ApplicableCompleted

The Goodnight Screen Media Study

Role: lead

NCT02098863Recruiting

Sickle Cell Clinical Research and Intervention Program

Role: collaborator

NCT05783297Not ApplicableCompleted

Midwest TXTXT Scale up of an Evidence-Based Intervention to Promote HIV Medication Adherence

Role: collaborator

NCT07368595Phase 4Not Yet Recruiting

Comparison of Conjunctival Goblet Cell Density in Dry Eye Patients Treated With Cyclosporine 0.1% Dissolved in Perfluorobutylpentane (Vevye®) or Generic 0.05% Cyclosporine Emulsion for 8 Weeks

Role: lead

NCT06274164Recruiting

Clinical and Molecular Biomarker Studies in RAI1 (Retinoic Acid-Induced 1) -Related Disorders

Role: lead

NCT06192745Not ApplicableRecruiting

SCREENS: Sleep, Circadian Rhythms, and Electronics in the EveNing Study

Role: lead

NCT01333046Phase 1Active Not Recruiting

Administration of TAA-Specific CTLs; Hodgkin or Non-Hodgkin Lymphoma; TACTAL

Role: lead

NCT06782906Not ApplicableRecruiting

Effect of Increased Physical Activity and Stopping Evening Snacking in Metabolic Health in Youth With Prediabetes

Role: lead

NCT04903080Phase 1Active Not Recruiting

HER2-specific Chimeric Antigen Receptor (CAR) T Cells for Children With Ependymoma

Role: collaborator

NCT07281261Not ApplicableRecruiting

tAN for Substance Use Disorder

Role: collaborator